Compare Apple Inc (AAPL) vs Aurora Cannabis Inc (ACB) Price & Performance

Apple (AAPL) trades at $313.27, up 0.2% today, with a bullish technical outlook and strong institutional support. The stock shows robust fundamentals with 2025 revenue of $416.16B and net income of $112.01B, though valuation ratios like P/E of 37.61 are elevated. Recent news highlights AI integration via Alphabet's Gemini and ongoing retail adjustments, including store closures amid union disputes.

Outlook remains positive with analyst consensus targeting $329.62, but risks include high valuation sensitivity and competitive pressures. Earnings have consistently beaten estimates, supporting growth potential, yet investors should monitor margin pressures and regulatory scrutiny in key markets.

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.